214 related articles for article (PubMed ID: 6883347)
1. Nonrandom chromosome changes in malignant melanoma.
Becher R; Gibas Z; Karakousis C; Sandberg AA
Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
[TBL] [Abstract][Full Text] [Related]
2. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
4. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
5. DNA content and chromosomal composition of malignant human gliomas.
Bigner SH; Bjerkvig R; Laerum OD
Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
[TBL] [Abstract][Full Text] [Related]
6. Consistent karyotypic abnormalities in human malignant melanomas.
Kacker RK; Giovanella BC; Pathak S
Anticancer Res; 1990; 10(4):859-71. PubMed ID: 2382982
[TBL] [Abstract][Full Text] [Related]
7. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
Kovacs G; Frisch S
Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic studies of human malignant melanoma cell lines.
Yin M; Yoshida MA; Tonomura A; Kasuga T
Bull Tokyo Med Dent Univ; 1992 Jun; 39(2):43-54. PubMed ID: 1505069
[TBL] [Abstract][Full Text] [Related]
9. Common and individually specific chromosomal characteristics of cultured human melanoma.
McCulloch PB; Dent PB; Hayes PR; Liao SK
Cancer Res; 1976 Feb; 36(2 Pt 1):398-404. PubMed ID: 944091
[TBL] [Abstract][Full Text] [Related]
10. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
[TBL] [Abstract][Full Text] [Related]
11. Nonrandom chromosome alterations in human malignant mesothelioma.
Popescu NC; Chahinian AP; DiPaolo JA
Cancer Res; 1988 Jan; 48(1):142-7. PubMed ID: 3334988
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic characterization of tumors of the vulva and vagina.
Micci F; Teixeira MR; Scheistrøen M; Abeler VM; Heim S
Genes Chromosomes Cancer; 2003 Oct; 38(2):137-48. PubMed ID: 12939741
[TBL] [Abstract][Full Text] [Related]
14. Nonrandom abnormalities in chromosome 1 in human testicular cancers.
Wang N; Trend B; Bronson DL; Fraley EE
Cancer Res; 1980 Mar; 40(3):796-802. PubMed ID: 7471097
[TBL] [Abstract][Full Text] [Related]
15. Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma.
Trent JM; Meyskens FL; Salmon SE; Ryschon K; Leong SP; Davis JR; McGee DL
N Engl J Med; 1990 May; 322(21):1508-11. PubMed ID: 2336077
[TBL] [Abstract][Full Text] [Related]
16. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
17. Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma.
Pedersen MI; Bennett JW; Wang N
Cancer Genet Cytogenet; 1986 Feb; 20(1-2):11-27. PubMed ID: 3943054
[TBL] [Abstract][Full Text] [Related]
18. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
[TBL] [Abstract][Full Text] [Related]
19. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
Mrózek K; Heinonen K; Theil KS; Bloomfield CD
Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
